| abstract |
In the general formula (I) of the compounds of the present invention, W, Y, A, B, D, and E are independently an organic tuber, Z is an xenogene or sulfur atom, or an organic tube coat. 0 or 1, with the proviso, at least one of them has a value other than 0, the value of g, h and h independently of one another is 0, 1, 2, 3, 4, 5 or 6.The compounds of the invention are generally represented by general formula (I) the use of a pharmaceutical composition containing these compounds for the treatment or prevention of anthrax diseases, which is associated with undesirable adhesion and / or migration of stalactites, or in which VLA-4 receptors and ligands of their ligands play a role in primitive cell-cell or cell-matrix interactions, such as disoriented hematomas, rheumatoid arthritis; or allergic diseases. The present invention further provides pharmaceutical compositions for use in the treatment of diseases of the general formula (I). |